RYAHF (RYAH Group) Accounts Payable: $0.60 Mil (As of Sep. 2022)


What is RYAH Group Accounts Payable?

RYAH Group RYAHF Accounts Payable is $0.60 Mil as of Sep. 2022.

RYAH Group's Accounts Payable for the quarter that ended in Sep. 2022 was $0.60 Mil.

RYAH Group's quarterly Accounts Payable increased from Mar. 2022 ($0.52 Mil) to Jun. 2022 ($0.59 Mil) and increased from Jun. 2022 ($0.59 Mil) to Sep. 2022 ($0.60 Mil).

RYAH Group's annual Accounts Payable increased from . 20 ($0.00 Mil) to Dec. 2020 ($0.46 Mil) and increased from Dec. 2020 ($0.46 Mil) to Dec. 2021 ($0.47 Mil).


RYAH Group Accounts Payable Historical Data

* Premium members only.

The historical data trend for RYAH Group's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RYAH Group Accounts Payable Chart

RYAH Group Annual Data
Trend Dec20 Dec21
Accounts Payable
0.46 0.47

RYAH Group Quarterly Data
Feb20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Accounts Payable Get a 7-Day Free Trial 0.79 0.47 0.52 0.59 0.60

RYAH Group Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.60 Mil mean?
RYAH Group (RYAHF) has a Accounts Payable of $0.60 Mil as of Sep. 2022. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on RYAH Group and its competitors.
Is RYAH Group's Accounts Payable too high?
RYAH Group's current Accounts Payable is $0.60 Mil.
How does RYAH Group's Accounts Payable compare to CERN and VEEV?
RYAH Group's Accounts Payable of $0.60 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Providers & Services company?
A good Accounts Payable depends on the Healthcare Providers & Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on RYAH Group and its competitors. RYAH Group's current Accounts Payable is $0.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RYAH Group stock overvalued right now?
RYAH Group (RYAHF) has a current Accounts Payable of $0.60 Mil. The current Accounts Payable is $0.60 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For RYAH Group (RYAHF), the current Accounts Payable is $0.60 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RYAH Group Business Description

Address 68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.